Background Extracorporeal life support (ECLS) is increasingly used in the treatment of
infarct-related cardiogenic shock despite a lack of evidence regarding its effect on mortality. …

… by cardiogenic shock the use of mechanical circulatory support … life support (ECLS) -
venoarterial extracorporeal membrane oxygenation - provides the strongest hemodynamic support …

… VA-ECMO: a form of extracorporeal life support where blood is withdrawn from the venous
system and then infused into the arterial system to provide partial or complete circulatory or …

… paroxysmal hypertension to intractable cardiogenic shock. Extracorporeal life support, in
veno… However, its clinical utility in phaeochromocytoma-induced cardiogenic shock remains still …

… life support (ECLS) in acute myocardial infarction (AMI) complicated by cardiogenic shock
(CS… measured by 30 day ejection fraction in the ECLS-SHOCK trial. However, to date, no data …

… Of these, 56 (10.8%) were supported for cardiogenic shock due to AMI and met our inclusion
criteria. The mean age was 56.7 ± 9.7 (range, 27–71) years and 89.3% were males. Table …

… between 2010 and 2019, we compared in-hospital mortality and length of stay, predictors
of OHT versus LVAD, and predictors of in-hospital mortality for patients with cardiogenic shock …

OBJECTIVES Fulminant myocarditis with cardiogenic shock requires extracorporeal life support
(ECLS) and has poor outcomes. To improve outcomes, we have converted patients with …

OBJECTIVES: Because significantly higher mortality is observed in elderly patients undergoing
venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock, …

… therapeutic alternatives in patients with refractory cardiogenic shock.1, 2, 3, 4, 5 … Life
Support Organization (ELSO) Registry, we compared in-hospital outcomes in cardiogenic shock …